For: | Zhang DH, Zhou LY, Dong XY, Cui RL, Xue Y, Lin SR. Factors influencing intercellular spaces in the rat esophageal epithelium. World J Gastroenterol 2010; 16(9): 1063-1069 [PMID: 20205275 DOI: 10.3748/wjg.v16.i9.1063] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i9/1063.htm |
Number | Citing Articles |
1 |
Lori A. Birder, Ann T. Hanna‐Mitchell, Emeran Mayer, Charles A. Buffington. Cystitis, Co‐morbid disorders and associated epithelial dysfunction. Neurourology and Urodynamics 2011; 30(5): 668 doi: 10.1002/nau.21109
|
2 |
Hiroki Mori, Masato Koike, Takahiro Gotow, Koichiro Ichimura, Daisuke Asaoka, Masako Oguro, Akihito Nagahara, Takashi Ueno, Yasuo Uchiyama, Sumio Watanabe. <b>Ultrastructural analyses of the rat esophageal stratified epithelium under normal conditions and in chronic reflux esophagitis </b>. Archives of Histology and Cytology 2011; 73(4+5): 199 doi: 10.1679/aohc.73.199
|
3 |
P. J. Rosch. Letter: proton pump inhibitors, GERD and oesophageal adenocarcinoma. Alimentary Pharmacology & Therapeutics 2014; 40(3): 319 doi: 10.1111/apt.12832
|
4 |
C. Prakash Gyawali, Daniel Sifrim, Dustin A. Carlson, Mary Hawn, David A. Katzka, John E. Pandolfino, Roberto Penagini, Sabine Roman, Edoardo Savarino, Roger Tatum, Michel Vaezi, John O. Clarke, George Triadafilopoulos. Ineffective esophageal motility: Concepts, future directions, and conclusions from the Stanford 2018 symposium. Neurogastroenterology & Motility 2019; 31(9) doi: 10.1111/nmo.13584
|
5 |
Leila Kia, John E. Pandolfino, Peter J. Kahrilas. Biomarkers of Reflux Disease. Clinical Gastroenterology and Hepatology 2016; 14(6): 790 doi: 10.1016/j.cgh.2015.09.014
|
6 |
Marie–Pier Tetreault, Mei–Lun Wang, Yizeng Yang, Jenna Travis, Qian–Chun Yu, Andres J. Klein–Szanto, Jonathan P. Katz. Klf4 Overexpression Activates Epithelial Cytokines and Inflammation-Mediated Esophageal Squamous Cell Cancer in Mice. Gastroenterology 2010; 139(6): 2124 doi: 10.1053/j.gastro.2010.08.048
|
7 |
Paul Rosch. Could proton pump inhibitors cause cancer?. Expert Review of Clinical Pharmacology 2014; 7(2): 109 doi: 10.1586/17512433.2014.867233
|
8 |
R. Farré. Pathophysiology of gastro‐esophageal reflux disease: a role for mucosa integrity?. Neurogastroenterology & Motility 2013; 25(10): 783 doi: 10.1111/nmo.12201
|
9 |
PAULA ESQUIVIAS, CARMELO CEBRIÁN, ANTONIO MORANDEIRA, SONIA SANTANDER, JAVIER ORTEGO, MARÍA ASUNCIÓN GARCÍA-GONZÁLEZ, ANGEL LANAS, ELENA PIAZUELO. Effect of aspirin treatment on the prevention of esophageal adenocarcinoma in a rat experimental model. Oncology Reports 2014; 31(6): 2785 doi: 10.3892/or.2014.3137
|
10 |
Priya Sharma, Rena Yadlapati. Pathophysiology and treatment options for gastroesophageal reflux disease: looking beyond acid. Annals of the New York Academy of Sciences 2021; 1486(1): 3 doi: 10.1111/nyas.14501
|
11 |
Jia Cheng Tan, Wen Xia Cui, Ding Heng, Lin Lin. ERK1/2 participates in regulating the expression and distribution of tight junction proteins in the process of reflux esophagitis. Journal of Digestive Diseases 2014; 15(8): 409 doi: 10.1111/1751-2980.12163
|
12 |
Takashi Amemiya, Kenichi Shibata, Junpei Takahashi, Masatoshi Watanabe, Satoshi Nakata, Kazuyuki Nakamura, Tomohiko Yamaguchi. Glycolytic oscillations in HeLa cervical cancer cell spheroids. The FEBS Journal 2022; 289(18): 5551 doi: 10.1111/febs.16454
|